Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.
Wataru FukuokayaYuhei KoikeYuji YataKazumasa KomuraTaizo UchimotoTakuya TsujinoMasanobu SarutaKiyoshi TakaharaKazutoshi FujitaTakafumi MinamiTakahiro AdachiYosuke HirasawaTakeshi HashimotoYoshio OhnoHirotsugu UemuraRyoichi ShirokiHaruhito AzumaTakahiro KimuraPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)
This study describes the characteristics and outcomes of patients with previously treated advanced urothelial cancer receiving EV. The findings demonstrate that EV showed robust anti-tumor activity and had manageable safety profiles outside the clinical trial setting.